IDEXX Labs (IDXX) Tops Q2 EPS by 10c, Beats on Revenues; Offers FY17 EPS / Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
IDEXX (IDXX) Oversold, Buy on Weakness - Stifel
August 1, 2017 12:31 PM EDTStifel analyst Jonathan Block sees shares of IDEXX Laboratories (NASDAQ: IDXX) as oversold and reiterated a Buy rating and price target of $185.
Block called the quarter "solid" with a raised outlook but notes shares are under pressure as the magnitude of the beat and... More
CL King Upgrades IDEXX Laboratories (IDXX) to Buy
July 28, 2017 9:26 AM EDTCL King upgraded IDEXX Laboratories (NASDAQ: IDXX) from Neutral to Buy with a price target of $200.00.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $164.40 yesterday.
... More